Good solid result - company in rude health now having...

Good solid result - company in rude health now having deleveraged Bal sheet with sale of Aus Tissue business. Little disappointed no Div but suspect prudently building cash for Covid weakness defensive position and so ready to pounce on suitable growth driving acquisitions if/when they come up.

AFR quoting Citi analysts valuing AHY at $1.30.

Good one to hold and rest easy with, should do well over Medium term horizon.